CIBMTR Reporting Implementation Guide - Local Development build (v0.1.6). See the Directory of published versions
{
"resourceType" : "MedicationRequest",
"id" : "MedicationRequest-Etoposide-Example",
"meta" : {
"profile" : [
"http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-medication-request"
],
"security" : [
{
"system" : "http://terminology.cibmtr.org/codesystem/transplant-center",
"code" : "rc_99999",
"display" : "99999 My Transplant Center"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"MedicationRequest-Etoposide-Example\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest "MedicationRequest-Etoposide-Example" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-cibmtr-medication-request.html\">CIBMTR Medication Request (mcode)</a></p><p style=\"margin-bottom: 0px\">Security Labels: <span title=\"{http://terminology.cibmtr.org/codesystem/transplant-center http://terminology.cibmtr.org/codesystem/transplant-center}\">http://terminology.cibmtr.org/codesystem/transplant-center</span></p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: <a href=\"Medication-Medication-Etoposide-Example.html\">Medication/Medication-Etoposide-Example: etoposide (VEPESID) chemo IVPB</a></p><p><b>subject</b>: <a href=\"Patient-PatientExample6.html\">Patient/PatientExample6</a> ""</p><p><b>authoredOn</b>: 2020-07-21 14:17:00+0000</p><p><b>requester</b>: <span>: unknown</span></p><p><b>reasonCode</b>: Cancer (CMS/HCC) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#363346000 "Malignant neoplastic disease (disorder)"; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-icd10CM.html\">International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)</a>#C80.1 "Malignant (primary) neoplasm, unspecified")</span></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: 68 mg (100 mg/m2 x 0.68 m2 Treatment plan actual BSA), Intravenous, for 60 Minutes, Every 24 hours, First dose on Tue 11/19/13 at 0000, For 5 doses\nGive after CISplatin and mannitol.</p><p><b>timing</b>: Code: Every 24 hours, Starting 2020-07-22 16:58:05+0000, Count 5 times, Duration 60hours, Once per 24 hours, Until 2020-07-22 16:58:05+0000</p><p><b>asNeeded</b>: false</p><p><b>route</b>: Intravenous central route (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#418114005)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>"
},
"status" : "active",
"intent" : "order",
"medicationReference" : {
"reference" : "Medication/Medication-Etoposide-Example",
"display" : "etoposide (VEPESID) chemo IVPB"
},
"subject" : {
"reference" : "Patient/PatientExample6"
},
"authoredOn" : "2020-07-21T14:17:00Z",
"requester" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
"valueCode" : "unknown"
}
],
"display" : "unknown"
},
"reasonCode" : [
{
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "363346000",
"display" : "Malignant neoplastic disease (disorder)"
},
{
"system" : "http://hl7.org/fhir/sid/icd-10-cm",
"code" : "C80.1",
"display" : "Malignant (primary) neoplasm, unspecified"
}
],
"text" : "Cancer (CMS/HCC)"
}
],
"dosageInstruction" : [
{
"text" : "68 mg (100 mg/m2 x 0.68 m2 Treatment plan actual BSA), Intravenous, for 60 Minutes, Every 24 hours, First dose on Tue 11/19/13 at 0000, For 5 doses\nGive after CISplatin and mannitol.",
"timing" : {
"repeat" : {
"boundsPeriod" : {
"start" : "2020-07-22T16:58:05Z",
"end" : "2020-07-22T16:58:05Z"
},
"count" : 5,
"duration" : 60,
"durationUnit" : "min",
"frequency" : 1,
"period" : 24,
"periodUnit" : "h"
},
"code" : {
"text" : "Every 24 hours"
}
},
"asNeededBoolean" : false,
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "418114005",
"display" : "Intravenous central route (qualifier value)"
}
]
},
"doseAndRate" : [
{
"type" : {
"text" : "admin-amount"
},
"doseQuantity" : {
"value" : 68,
"unit" : "milligram",
"system" : "http://unitsofmeasure.org",
"code" : "mg"
}
},
{
"type" : {
"text" : "ordered"
},
"doseQuantity" : {
"value" : 100,
"unit" : "milligram per square meter",
"system" : "http://unitsofmeasure.org",
"code" : "mg/m2"
}
}
]
}
]
}
IG © 2020+ The Medical College of Wisconsin, Inc. and the National Marrow Donor Program
Package nmdp.fhir.cibmtr-reporting#0.1.6 based on FHIR 4.0.1. Generated 2023-05-05
Links: Table of Contents |
QA Report
HL7®, and FHIR® are the registered trademarks of Health Level Seven International
and their use of these trademarks does not constitute an endorsement by HL7.